Jul 2021

HTW Strategic Plan 2021-25 is published

We are pleased to announce the publication of the HTW Strategic Plan 2021 – 25, developed in consultation with our key stakeholders and endorsed by the Welsh Minister for Health and Social Services.

Jul 2021

Guidance published: Haemodialysis antimicrobial barrier caps

We appraised the clinical and cost effectiveness of Haemodialysis antimicrobial barrier caps.

‘Advice on Health Technologies’ bulletin published

We’ve published the ‘Advice on Health Technologies’ bulletin to support decision making on health technologies within NHS Wales. The bulletin lists advice and guidance published by us and other health technology assessment (HTA) agencies across the UK and Europe from April to June 2021.

May 2021

Guidance published: Point-of-care ultrasound to diagnose gallstone disease

We appraised the clinical and cost effectiveness of point-of-care ultrasound to diagnose gallstone disease.

Guidance published: Corneal cross-linking (CXL)

We appraised the clinical and cost effectiveness of corneal cross-linking (CXL) for the treatment of adults and children with keratoconus.

Apr 2021

‘Advice on Health Technologies’ bulletin published

We’ve published the ‘Advice on Health Technologies’ bulletin to support decision making on health technologies within NHS Wales. The bulletin lists advice and guidance published by us and other health technology assessment (HTA) agencies across the UK and Europe from January to March 2021.

Apr 2021

Health Technology Wales seeks suggestions of innovations that transform care

Health Technology Wales is looking for ideas from across health and social care to improve the quality of care in Wales.

Mar 2021

Health Technology Wales to partner with Wales COVID-19 Evidence Centre

The national Health Technology Assessment (HTA) body will provide research expertise and input to the brand-new £3m centre for COVID-19 topics.

Mar 2021

HTW Strategic Plan – Stakeholder consultation

We’re seeking the views of external stakeholders on the content and direction of our strategy. You’re invited to provide your feedback on the form below.